Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline

Victor Chedid, Priya Vijayvargiya, Michael Camilleri

Research output: Contribution to journal › Editorial › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline'. Together they form a unique fingerprint.